Potential role of IGF-1R in the interaction between orbital fibroblasts and B lymphocytes: an implication for B lymphocyte depletion in the active inflammatory phase of thyroid-associated ophthalmopathy

BMC Immunol. 2024 May 11;25(1):31. doi: 10.1186/s12865-024-00613-3.

Abstract

Background: Thyroid eye disease (TED) is an inflammatory process involving lymphocyte-mediated immune response and orbital tissue damage. The anti-insulin-like growth factor-1 receptor (IGF-1R) antibodies produced by B lymphocytes are involved in the activation of orbital fibroblasts and the inflammatory process of orbital tissue damage in TED. The purpose of this study was to explore the role of IGF-1R in the mechanistic connection between orbital fibroblasts and B lymphocytes in TED.

Methods: Orbital fibroblasts sampled from orbital connective tissues and peripheral B lymphocytes isolated from peripheral blood, which were obtained from 15 patients with TED and 15 control patients, were co-cultured at a ratio of 1:20. The level of IGF-1R expression in orbital fibroblasts was evaluated by flow cytometry and confocal microscopy. Transient B lymphocyte depletion was induced with anti-CD20 monoclonal antibody rituximab, while the IGF-1R pathway was blocked by the IGF-1R binding protein. The expression levels of interleukin-6 (IL-6) and regulated upon activation, normal T cell expressed and secreted (RANTES) in the co-culture model were quantified via ELISA.

Results: IGF-1R expression was significantly elevated in TED orbital fibroblasts compared to that of controls. A 24-h co-culture of orbital fibroblasts with peripheral B lymphocytes induced elevated expression levels of IL-6 and RANTES in each group (TED patients and controls), with the highest levels occurring in TED patients (T + T group). Rituximab and IGF-1R binding protein significantly inhibited increased levels of IL-6 and RANTES in the co-culture model of TED patients.

Conclusions: IGF-1R may mediate interaction between orbital fibroblasts and peripheral B lymphocytes; thus, blocking IGF-1R may reduce the local inflammatory response in TED. Rituximab-mediated B lymphocyte depletion played a role in inhibiting inflammatory responses in this in vitro co-culture model, providing a theoretical basis for the clinical application of anti-CD20 monoclonal antibodies in TED.

Keywords: B lymphocytes; Insulin-like growth factor-1 receptor; Orbital fibroblasts; Thyroid-associated ophthalmopathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • B-Lymphocytes* / immunology
  • B-Lymphocytes* / metabolism
  • Cell Communication
  • Cells, Cultured
  • Chemokine CCL5 / metabolism
  • Coculture Techniques*
  • Female
  • Fibroblasts* / metabolism
  • Graves Ophthalmopathy* / immunology
  • Graves Ophthalmopathy* / metabolism
  • Humans
  • Interleukin-6 / metabolism
  • Lymphocyte Depletion
  • Male
  • Middle Aged
  • Orbit / immunology
  • Orbit / metabolism
  • Receptor, IGF Type 1* / metabolism
  • Rituximab / pharmacology
  • Rituximab / therapeutic use

Substances

  • Receptor, IGF Type 1
  • Rituximab
  • Interleukin-6
  • Chemokine CCL5